What are the targets for early breast cancer treatment? What’s the story?
1. Complete elimination of tumours: elimination of tumour tissues and prevention of cancer cell residues to the fullest extent possible by means of surgery, treatment, chemotherapy, etc. 2. Prevention of relapse: Integrated treatment to reduce the risk of relapse and diversion and to increase the long-term survival of patients. It is generally believed that after treatment, a clinical cure can be considered to have been achieved if there are no relapses and transfers in five years. This does not, however, mean a complete cure, and the patient still needs to undergo regular review in order to detect a possible recurrence or transfer at an early stage. The clinical treatment of breast cancer is characterized by the following: 2. Pain relief: including breast and armpit pain, pain symptoms caused by breast cancer are significantly reduced until they disappear. Absorption of the nipple spill: If there is a nipple spill at the time of the disease, there will be no spill after the treatment. 1. Visually normal: – Breast ultrasound does not reveal abnormal manifestations such as echoes, blood flow signals, etc. – Monoton targeting shows suspicious changes in mammograms, calcified points, swollen shadings, etc. – The MRI examination also showed no signs of tumour. 2. Oncology markers are normal: values of tumor markers, such as cancer embryo antigens (CEA), sugar antigens 15-3 (CA15-3), are within normal range. 1. Physical recovery: The patient feels that he/she is gradually recovering and able to perform his/her daily activities and moderate physical labour, and is no longer as vulnerable to fatigue as he/she is in case of illness. 2. Improved appetite: A return to normal eating habits and a general return to pre-disease levels of diet and dietary preferences. 3. Good sleep: sleep quality is improved and there is no longer insomnia, dreams, etc. caused by disease. In general, after treatment, breast cancer patients are considered to have achieved a clinical cure if no relapse or transfer occurs in five years, but still need to be reviewed regularly to ensure that the condition is stable.
Breast cancer
